Literature DB >> 15559314

[Case of anterior ischemic optic neuropathy accompanied by Churg-Strauss syndrome].

Kenji Hayakawa1, Ichiko Akatsuka, Shuji Matsukura, Kenji Kawai, Hirohisa Ohkuma, Kazuo Shimamura.   

Abstract

BACKGROUND: Churg-Strauss syndrome (CSS) is a vasculitis which includes the three signs of bronchial asthma, hypereosinophilia, and vasculitis syndrome. We report a case in whom anterior ischemic optic neuropathy (AION) accompanied CSS. Such a case has not been reported previously in Japan. CASE: A 66-year-old woman with a history of bronchial asthma and eosinophilic pneumonia was hospitalized for fever, unusual feelings in both plantae and in a finger of her left hand, disturbance of visual acuity and visual field in the right eye, and skin rashes; a diagnosis of CSS was made. At the time of the first ophthalmological examination, AION was observed. Steroid therapy was started, but the treatment was not effective, despite an improvement in choroidal circulation confirmed by fluorescein angiography and indocyanine green angiography. In the unaffected eye, soft exudates appeared when the steroid dose was lowered and disappeared when the steroid dose was raised.
CONCLUSION: Anterior ischemic optic neuropathy accompanied with Churg-Strauss syndrome resisted medical treatment and the prognosis was poor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15559314

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  3 in total

1.  Initial neuro-ophthalmological manifestations in Churg-Strauss syndrome.

Authors:  Anne-Evelyne Vallet; Adrien Didelot; Fitsum Guebre-Egziabher; Martine Bernard; François Mauguière
Journal:  BMJ Case Rep       Date:  2010-10-12

Review 2.  Autoimmune optic neuropathy.

Authors:  James Goodwin
Journal:  Curr Neurol Neurosci Rep       Date:  2006-09       Impact factor: 5.081

Review 3.  [Ocular manifestations of Churg-Strauss syndrome: review article and case report].

Authors:  A Atili; C Richter; E Bahn; H H Rustenbeck; M Schittkowski
Journal:  Ophthalmologe       Date:  2013-11       Impact factor: 1.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.